A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s457761 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Mingyue Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, the First Hospital of China Medical University, Shenyang, 110001, People's Republic of China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, the First Hospital of China Medical University, Shenyang, 110001, People's Republic of China.
- NHC Key Laboratory of Immunodermatology, China Medical University, Shenyang, People's Republic of China.
- Key Laboratory of Immunodermatology, China Medical University, Ministry of Education, Shenyang, People's Republic of China.
- National and Local Joint Engineering Research Center of Immunodermatological Theranostics, Shenyang, People's Republic of China.
ORCID-Profile: Li Zhang
Zitieren
APA
Wang, M., Gao, X. H., & Zhang, L. (2024). A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s457761
Vancouver
Wang M, Gao XH, Zhang L. A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s457761
BibTeX
@article{Wang2024,
author = {Wang, Mingyue and Gao, Xing-Hua and Zhang, Li},
title = {A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s457761}
}
EUVIMED